Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
Express Scripts
Medtronic
Baxter
Johnson and Johnson

Last Updated: February 9, 2023

Desmopressin acetate - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic drug sources for desmopressin acetate and what is the scope of patent protection?

Desmopressin acetate is the generic ingredient in eleven branded drugs marketed by Ferring Pharms Inc, Am Regent, Bedford, Dr Reddys, Gland Pharma Ltd, Hospira, Sagent Pharms Inc, Sun Pharm Inds Ltd, Teva Pharms Usa, UBI, Ferring, Sun Pharm Inds, Bausch, Apotex Inc, Sun Pharm, Zydus Pharms, Acerus Pharms, Abhai Llc, Actavis Labs Fl Inc, Glenmark Pharms Ltd, Heritage Pharma, Impax Labs Inc, Mylan, and Novast Labs, and is included in thirty-four NDAs. There are thirteen patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Desmopressin acetate has two hundred and five patent family members in thirty-six countries.

There are thirteen drug master file entries for desmopressin acetate. Twenty-five suppliers are listed for this compound.

Drug Prices for desmopressin acetate

See drug prices for desmopressin acetate

Recent Clinical Trials for desmopressin acetate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Cairo UniversityN/A
Indiana Hemophilia &Thrombosis Center, Inc.Phase 4
Genentech, Inc.Phase 4

See all desmopressin acetate clinical trials

US Patents and Regulatory Information for desmopressin acetate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bedford DESMOPRESSIN ACETATE PRESERVATIVE FREE desmopressin acetate INJECTABLE;INJECTION 074574-001 Feb 18, 2000 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Sagent Pharms Inc DESMOPRESSIN ACETATE desmopressin acetate INJECTABLE;INJECTION 204751-001 Aug 22, 2017 AP RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Ferring Pharms Inc NOCDURNA desmopressin acetate TABLET;SUBLINGUAL 022517-001 Jun 21, 2018 RX Yes No See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Glenmark Pharms Ltd DESMOPRESSIN ACETATE desmopressin acetate TABLET;ORAL 201831-001 May 28, 2015 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Acerus Pharms NOCTIVA desmopressin acetate SPRAY, METERED;NASAL 201656-002 Mar 3, 2017 DISCN Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Bedford DESMOPRESSIN ACETATE desmopressin acetate INJECTABLE;INJECTION 074575-001 Feb 18, 2000 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for desmopressin acetate

International Patents for desmopressin acetate

Country Patent Number Title Estimated Expiration
Portugal 2712622 See Plans and Pricing
Denmark 3225250 See Plans and Pricing
Taiwan I315202 See Plans and Pricing
Portugal 3679941 See Plans and Pricing
Israel 213699 מכשיר למתן תוך-אפי של דזמופרסין (Intranasal desmopressin dispenser) See Plans and Pricing
Denmark 2550007 See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for desmopressin acetate

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
3225249 300983 Netherlands See Plans and Pricing PRODUCT NAME: DESMOPRESSIN, DESGEWENST IN DE VORM VAN EEN ACETAAT ZOUT; REGISTRATION NO/DATE: BE497271 & BE497280 20160513
2712622 LUC00015 Luxembourg See Plans and Pricing PRODUCT NAME: DESMOPRESSINE OU UN DE SES SELS D'ACETATE; AUTHORISATION NUMBER AND DATE: 497271; 497280 20161101
3225249 2019C/520 Belgium See Plans and Pricing PRODUCT NAME: DESMOPRESSINE OF EEN ACETAATZOUT DAARVAN; AUTHORISATION NUMBER AND DATE: BE497271 - BE497280 20160513
2712622 122017000006 Germany See Plans and Pricing PRODUCT NAME: DESMOPRESSIN ODER DAS ACETAT DAVON; NAT. REGISTRATION NO/DATE: 94725.00.00 94726.00.00 20160901 FIRST REGISTRATION: BELGIEN BE497271 BE497280 20160504
2712622 C02712622/01 Switzerland See Plans and Pricing PRODUCT NAME: DESMOPRESSIN; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 66379 16.03.2018
3225249 CA 2019 00023 Denmark See Plans and Pricing PRODUCT NAME: DESMOPRESSIN ELLER ET ACETATSALT DERAF; NAT. REG. NO/DATE: 55858, 55859 (DK) 20160526; FIRST REG. NO/DATE: BE BE497271, BE497280 20160504
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
Johnson and Johnson
Harvard Business School
Moodys
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.